NCT05608863Active, not recruiting
He-move-philia, Lifestyle Intervention for Patients With Hemophilia
He-move-philia, a Combined Lifestyle Intervention Program for Patients With Hemophilia and Other Bleeding Disorders
Source: ClinicalTrials.gov · Last updated 11 Aug 2025
Brief summary (registry, in English)
The main objectives are reduction of body weight, BMI and abdominal circumference. Secondary objectives are reduction of bleeds and units coagulation factor concentrate used, blood-pressure, cholesterol spectrum, glucose and improvement of physical activity and dietary habits. one group of patients will receive a combined lifestyle intervention program with individual sessions and group sessions lasting for 2 years, the other group of patients will receive individual sessions only and will be given the same information as given in the group sessions, but on paper.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 26 Oct 2022
- Start date
- 2 Nov 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Haemophilia
- NCT number
- NCT05608863
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 2 Nov 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Health care insurance with CZ or ONVZ as these health insurances have no contract with Profitt Lifestylecoaching.
- A contraindication or inability for physical activity as judged by the treating hemophilia physician
- Participation in another research trial
- Unable to understand the written information
- Unable to sign the informed consent
- Unwilling to randomize to the combined or individual intervention group
Who the study is looking for
- Diagnosed with hemophilia A, B, FVII deficiency, fibrinogen deficiency, von Willebrand Disease or other bleeding disorder preferably requiring coagulation products for prophylaxis or on demand in case of bleeding
- ≥ 18 years of age
- BMI ≥ 30 kg/m2
- Motivated to change their lifestyle
- Being able to speak, read and understand the Dutch language
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radboudumc Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.